Drugs / ZG19018
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06237400 | May 2022 → May 2025 | — | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZG19018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06237400 ↗ |
| Route | Oral | “ZG19018 Given by PO (mouth)” NCT06237400 ↗ |